We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A Virginia-based biotech company has ...

Erythropoietin, a treatment for newborns with critically low levels of oxygen or blood supply to the brain at birth, does not prevent death or disability, according to a new multinational study. The ...

Neonatal seizures and hypoxic-ischaemic encephalopathy (HIE) represent critical neurological conditions with profound implications for early brain development and long-term neurodevelopmental outcomes ...

NORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences (“ReAlta”), Inc., a clinical mid-stage biotech company dedicated to addressing life-threatening rare diseases by harnessing the power of the immune ...

ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute ...

NORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to ...

Researchers at UHealth - the University of Miami Health System and the University of Miami Miller School of Medicine have shown that, in two cases, COVID-19 infection breached the placenta and caused ...

On Sept. 30, 2018, the plaintiff infant was born with hypoxic-ischemic encephalopathy at Reading Hospital. After the baby's birth, the hospital allegedly failed to provide him with therapeutic ...